Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HU-F-AIM: Evaluating HU-resistance in Polycythemia Vera Patients
NCT05853458Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jul 2023
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyurea in polycythemia vera (PV), sponsored by Novartis. Started Jul 2023; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT05853458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853458.